Literature DB >> 17621269

Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.

K Haraguchi1, M Ohsugi, Y Abe, K Semba, T Akiyama, T Yamamoto.   

Abstract

The Wnt signaling pathway is essential for embryonic development and carcinogenesis. Upon Wnt stimulation, beta-catenin is stabilized and associates with T-cell factor or lymphoid enhancing factor, thereby activating transcription of target genes. In the absence of Wnt stimulation, the level of beta-catenin is reduced via glycogen synthase kinase (GSK)-3beta-mediated phosphorylation and subsequent proteasome-dependent degradation. Here, we report the identification of Ajuba as a negative regulator of the Wnt signaling pathway. Ajuba is a member of LIM domain-containing proteins that contribute to cell fate determination and regulate cell proliferation and differentiation. We found that enforced expression of Ajuba destabilized beta-catenin and suppressed target gene expression. Ajuba promoted GSK-3beta-mediated phosphorylation of beta-catenin by reinforcing the association between beta-catenin and GSK-3beta. Furthermore, Wnt stimulation induced both accumulation of beta-catenin and destabilization of Ajuba. Our findings suggest that Ajuba is important for regulation of the Wnt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621269     DOI: 10.1038/sj.onc.1210644

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

Review 1.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

Review 2.  Leveraging Genomics for Head and Neck Cancer Treatment.

Authors:  J D Kemmer; D E Johnson; J R Grandis
Journal:  J Dent Res       Date:  2018-02-08       Impact factor: 6.116

3.  Suppression of the Wnt signaling pathway may contribute to the inhibition of proliferation of human hepatocellular carcinoma SMMC-7721 cells by esculetin.

Authors:  Xinfeng Fan; Haiyuan Du; Yaogui Sun; Junbing Jiang; Zhirui Wang; Wei Yin; Kuohai Fan; Hongquan Li
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

Review 4.  The molecular landscape of head and neck cancer.

Authors:  C René Leemans; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

5.  Phenotype-genotype correlations of facial width and height proportions in patients with Class II malocclusion.

Authors:  L M Moreno Uribe; A Ray; D R Blanchette; D V Dawson; T E Southard
Journal:  Orthod Craniofac Res       Date:  2015-04       Impact factor: 1.826

6.  Progenitor-derived hepatocellular carcinoma model in the rat.

Authors:  Jesper B Andersen; Roberto Loi; Andrea Perra; Valentina M Factor; Giovanna M Ledda-Columbano; Amedeo Columbano; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

7.  The LIM protein LIMD1 influences osteoblast differentiation and function.

Authors:  Hilary F Luderer; Shuting Bai; Gregory D Longmore
Journal:  Exp Cell Res       Date:  2008-06-09       Impact factor: 3.905

Review 8.  Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.

Authors:  De-Chen Lin; Ming-Rong Wang; H Phillip Koeffler
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 33.883

9.  Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.

Authors:  Joshua D Campbell; Christina Yau; Reanne Bowlby; Yuexin Liu; Kevin Brennan; Huihui Fan; Alison M Taylor; Chen Wang; Vonn Walter; Rehan Akbani; Lauren Averett Byers; Chad J Creighton; Cristian Coarfa; Juliann Shih; Andrew D Cherniack; Olivier Gevaert; Marcos Prunello; Hui Shen; Pavana Anur; Jianhong Chen; Hui Cheng; D Neil Hayes; Susan Bullman; Chandra Sekhar Pedamallu; Akinyemi I Ojesina; Sara Sadeghi; Karen L Mungall; A Gordon Robertson; Christopher Benz; Andre Schultz; Rupa S Kanchi; Carl M Gay; Apurva Hegde; Lixia Diao; Jing Wang; Wencai Ma; Pavel Sumazin; Hua-Sheng Chiu; Ting-Wen Chen; Preethi Gunaratne; Larry Donehower; Janet S Rader; Rosemary Zuna; Hikmat Al-Ahmadie; Alexander J Lazar; Elsa R Flores; Kenneth Y Tsai; Jane H Zhou; Anil K Rustgi; Esther Drill; Ronglei Shen; Christopher K Wong; Joshua M Stuart; Peter W Laird; Katherine A Hoadley; John N Weinstein; Myron Peto; Curtis R Pickering; Zhong Chen; Carter Van Waes
Journal:  Cell Rep       Date:  2018-04-03       Impact factor: 9.423

10.  Evidence for AJUBA-catenin-CDH4-linked differentiation resistance of mesenchymal stem cells implies tumorigenesis and progression of head and neck squamous cell carcinoma: a single-cell transcriptome approach.

Authors:  Andres Stucky; Li Gao; Lan Sun; Shengwen Calvin Li; Xuelian Chen; Tiffany H Park; Jin Cai; Mustafa H Kabeer; Xi Zhang; Uttam K Sinha; Jiang F Zhong
Journal:  Blood Genom       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.